XBiotech Ownership | Who Owns XBiotech?

XBiotech Ownership Summary

XBiotech is owned by 15.92% institutional investors, 35.11% insiders, and 48.97% retail investors. Blackrock is the largest institutional shareholder, holding 3.73% of XBIT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in XBiotech shares.

XBIT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	XBiotech	15.92%	35.11%	48.97%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	1.13M	3.73%	$5.83M
Vanguard group	1.04M	3.41%	$5.33M
Geode capital management	430.20K	1.41%	$2.21M
Millennium management	361.66K	1.19%	$1.86M
Ubs asset management americas	248.27K	0.82%	$1.28M
State street	202.84K	0.67%	$1.04M
Bridgeway capital management	154.18K	0.51%	$792.48K
Morgan stanley	100.55K	0.33%	$516.83K
Bank of new york mellon	98.31K	0.32%	$505.33K
Northern trust	78.41K	0.26%	$403.01K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bridgeway capital management	154.18K	0.02%	$792.48K
Empowered funds	69.14K	0.01%	$355.36K
Thomasville national bank	13.35K	0.01%	$68.62K
Connor, clark & lunn investment management	77.72K	0.00%	$399.50K
Millennium management	361.66K	0.00%	$1.86M
Synovus financial	11.80K	0.00%	$60.63K
Mcilrath & eck	753.00	0.00%	$3.87K
Ubs asset management americas	248.27K	0.00%	$1.28M
Corebridge financial	9.96K	0.00%	$51.27K
Ameritas investment partners	1.81K	0.00%	$9.32K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.13M	0.00%	827.52K
Ubs asset management americas	248.27K	0.00%	248.27K
Geode capital management	430.20K	0.00%	235.00K
State street	202.84K	-	146.32K
Vanguard group	1.04M	0.00%	141.65K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	361.66K	0.00%	-565.71K
Susquehanna group, llp	-	-	-169.81K
Jane street group	-	-	-54.82K
Goldman sachs group	13.17K	-	-48.99K
Hrt financial lp	-	-	-33.59K

New Positions

Holder	Shares	% Assets	Change	Value
Ubs asset management americas	248.27K	0.00%	248.27K	$1.28M
American century companies	76.46K	0.00%	76.46K	$393.00K
Nuveen asset management	24.88K	-	24.88K	$127.88K
New york state common retirement fund	21.70K	0.00%	21.70K	$112.00K
Corebridge financial	9.96K	0.00%	9.96K	$51.27K

Sold Out

Holder	Change
Simplex trading	-228.00
Macquarie group	-576.00
Cubist systematic strategies	-5.25K
Marshall wace, llp	-10.57K
Man group	-10.61K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	49	4.26%	4,851,469	7.42%	15	7.23%	32	-	6	-25.00%
Jun 30, 2024	47	-2.08%	4,516,464	13.05%	14	8.61%	32	23.08%	8	-20.00%
Mar 31, 2024	48	17.07%	3,994,955	15.90%	13	10.23%	26	36.84%	10	25.00%
Dec 31, 2023	41	5.13%	3,446,963	1.53%	11	9.10%	19	46.15%	8	-11.11%
Sep 30, 2023	39	-4.88%	3,395,153	-2.54%	11	8.52%	13	-35.00%	9	-10.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	623.36K	2.05%	-
iShares Russell 2000 ETF	450.93K	1.48%	-1.01K
Vanguard Institutional Extnd Mkt Idx Tr	292.55K	0.96%	-
iShares Russell 2000 Value ETF	187.80K	0.62%	-
Fidelity Small Cap Index	186.99K	0.61%	-2.09K
Fidelity Extended Market Index	114.59K	0.38%	-1.33K
Avantis US Small Cap Value ETF	106.59K	0.35%	-
Vanguard Russell 2000 ETF	90.96K	0.30%	-578.00
State St Russell Sm Cap® Indx SL Cl I	90.50K	0.30%	-
Bridgeway Ultra-Small Company	65.04K	0.21%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 03, 2024	SIMARD JOHN	Chief Executive Officer	Buy	$10.00M
Oct 18, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$431.25K
Oct 15, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$226.47K
Oct 13, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$139.53K
Oct 12, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$229.94K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	1	-
2023 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-

XBIT Ownership FAQ

Who Owns XBiotech?

XBiotech shareholders are primarily institutional investors at 15.92%, followed by 35.11% insiders and 48.97% retail investors. The average institutional ownership in XBiotech's industry, Biotech Stocks , is 47.04%, which XBiotech falls below.

Who owns the most shares of XBiotech?

XBiotech’s largest shareholders are Blackrock (1.13M shares, 3.73%), Vanguard group (1.04M shares, 3.41%), and Geode capital management (430.2K shares, 1.41%). Together, they hold 8.54% of XBiotech’s total shares outstanding.

Does Blackrock own XBiotech?

Yes, BlackRock owns 3.73% of XBiotech, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.83M$. In the last quarter, BlackRock increased its holdings by 827.52K shares, a 269.88% change.

Who is XBiotech’s biggest shareholder by percentage of total assets invested?

Bridgeway capital management is XBiotech’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 154.18K XBiotech shares, valued at 792.48K$.

Who is the top mutual fund holder of XBiotech shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of XBiotech shares, with 2.05% of its total shares outstanding invested in 623.36K XBiotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools